Peter Langguth

272 papers receiving 9.4k citations

Peter Langguth's Hit Papers

A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications 2011 · 214 citations
2140+5+10Years since publication50100150200

Peers

Peter Langguth
Comparison fields: 5 of 174
  • Pharmaceutical Science 3.4k
  • Pharmacology 805
  • Oncology 1.8k
  • Analytical Chemistry 645
  • Biomaterials 831
Replace Anette Müllertz with:
Anette Müllertz Denmark
William N. Charman Australia
Arik Dahan Israel
René Holm Denmark
Shinji Yamashita Japan
Christos Reppas Greece
Masaki Otagiri Japan
Patrick Augustijns Belgium
Christopher J. H. Porter Australia
Patrick J. Sinko United States
Peter Langguth relative to Anette Müllertz Denmark Anette Müllertz's profile →
Citations per field
00.5×1.5×
Anette Müllertz · 1×
Citations per year

Countries citing papers authored by Peter Langguth

Since Specialization
Citations

This map shows the geographic impact of Peter Langguth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Langguth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Langguth more than expected).

Fields of papers citing papers by Peter Langguth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Langguth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Langguth. The network helps show where Peter Langguth may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Langguth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Langguth Line = papers co-authored together Peter Langguth links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 279 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000394
2 2012287
3 2014271
4
A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer®), a new intravenous iron preparation and its clinical implications
Hit paper breakdown →
2011214
5 2015192
6 2020192
7 1998191
8 2007178
9 2008173
10 1997147
11 2004124
12 1999112
13 2001109
14 2003108
15 2009106
16 2015105
17 2001103
18 2008100
19 201299
20 199697

About Peter Langguth

Peter Langguth is a scholar working on Pharmaceutical Science, Oncology, Molecular Biology, Analytical Chemistry and Pediatrics, Perinatology and Child Health, having authored 279 papers that have together received 9.8k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (110 papers), Drug Transport and Resistance Mechanisms (53 papers), Advanced Drug Delivery Systems (46 papers), Analytical Methods in Pharmaceuticals (34 papers), Analytical Chemistry and Chromatography (22 papers), RNA Interference and Gene Delivery (20 papers), Crystallization and Solubility Studies (18 papers) and Pharmacogenetics and Drug Metabolism (17 papers). The work is most often cited by research in Pharmaceutical Science (3.4k citations), Pharmacology (805 citations), Oncology (1.8k citations), Analytical Chemistry (645 citations) and Biomaterials (831 citations). Peter Langguth has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Gordon L. Amidon, Hildegard Spahn‐Langguth, H. Spahn‐Langguth, Hans P. Merkle, Thomas Nawroth, Siegfried Wolffram, C G Regårdh, Jozef Al-Gousous, Constanze Hilgendorf and Abeer Hanafy. Their work appears in journals such as Journal of Pharmaceutical Sciences, European Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics, Pharmaceutical Research and Molecular Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact